# Filing Detail

Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001558370-23-010262
Filing Date
2023-05-19
Accepted
2023-05-19 16:56:02
Documents
1
Period of Report
2022-12-31
Effectiveness Date
2023-05-19

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | ARS | plx-20221231xars.pdf | ARS | 2155942
| Complete submission text file | 0001558370-23-010262.txt |  | 2970928

Mailing Address 2 UNIVERSITY PLAZA SUITE 100 HACKENSACK NJ 07601
Business Address 2 UNIVERSITY PLAZA SUITE 100 HACKENSACK NJ 07601 201-696-9345
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

EIN.: 650643773 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-33357 | Film No.: 23941180
SIC: 2836 Biological Products, (No Diagnostic Substances)